BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 29688883)

  • 1. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease.
    Tsiakanikas P; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
    Clin Chem Lab Med; 2018 May; 56(6):990-1000. PubMed ID: 29688883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
    Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
    Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients.
    Diamantopoulos MA; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
    Clin Chem Lab Med; 2017 May; 55(5):737-747. PubMed ID: 27930363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
    Kontos CK; Tsiakanikas P; Avgeris M; Papadopoulos IN; Scorilas A
    Mol Diagn Ther; 2017 Aug; 21(4):453-464. PubMed ID: 28405803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients.
    Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A
    Clin Chem Lab Med; 2014 Aug; 52(8):1217-27. PubMed ID: 24615484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
    Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A
    Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
    World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value.
    Rapti SM; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
    Clin Biochem; 2017 Nov; 50(16-17):918-924. PubMed ID: 28624481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein beta 3 (HSPB3) is an unfavorable molecular biomarker in colorectal adenocarcinoma.
    Kalioraki MA; Artemaki PI; Sklirou AD; Kontos CK; Adamopoulos PG; Papadopoulos IN; Trougakos IP; Scorilas A
    Mol Carcinog; 2020 Jan; 59(1):116-125. PubMed ID: 31709619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma.
    Adamopoulos PG; Kontos CK; Rapti SM; Papadopoulos IN; Scorilas A
    Int J Oncol; 2015 Feb; 46(2):849-59. PubMed ID: 25420464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
    Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
    World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
    Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Wang X; Wang J; Ma H; Zhang J; Zhou X
    Med Oncol; 2012 Jun; 29(2):919-27. PubMed ID: 21390519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
    Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
    Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of miR-20b-5p indicates favorable prognosis in laryngeal squamous cell carcinoma, especially in patients with non-infiltrated regional lymph nodes.
    Pantazis TL; Giotakis AI; Karamagkiolas S; Giotakis I; Konstantoulakis M; Liakea A; Misiakos EP
    Am J Otolaryngol; 2020; 41(5):102563. PubMed ID: 32521298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
    Li CF; Li YC; Wang Y; Sun LB
    Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression.
    Fang L; Li H; Wang L; Hu J; Jin T; Wang J; Yang BB
    Oncotarget; 2014 May; 5(10):2974-87. PubMed ID: 24912422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-675-5p Overexpression Is an Independent Prognostic Molecular Biomarker of Short-Term Relapse and Poor Overall Survival in Colorectal Cancer.
    Christodoulou S; Sotiropoulou CD; Vassiliu P; Danias N; Arkadopoulos N; Sideris DC
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.